Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DECA, DECAU | Denali Capital Acquisition Corp. | 10%+ Owner | May 21, 2022 | |||
ESLA, ESLAW | Estrella Immunopharma, Inc. | Chief Financial Officer | Sep 29, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|